You have 9 free searches left this month | for more free features.

Sarcoma, Myeloid

Showing 26 - 50 of 3,609

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extramedullary Acute Myeloid Leukemia: Retrospective Single

Completed
  • Acute Myeloid Leukemia
  • retrospective data analysis
  • Amman, Jordan
    King Hussein Cancer Center
Sep 15, 2021

Central Nervous System Involvement in Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • Observation of CNS involvement
  • Alessandria, Italy
  • +13 more
Dec 31, 2021

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Precision Medicine for Every Child With Cancer

Recruiting
  • Childhood Cancer
  • +5 more
  • Whole Genome Sequencing
  • +6 more
  • Adelaide, Australia
  • +8 more
Jan 24, 2023

Histiocytic Disorder Follow-up Study

Recruiting
  • Histiocytosis
  • +5 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 13, 2023

    NHL, Adult, AML, Adult Recurrent Trial in Zhengzhou, Tianjin (ETH-155008)

    Recruiting
    • NHL, Adult
    • AML, Adult Recurrent
    • Zhengzhou, Henan, China
    • +1 more
    Feb 24, 2023

    CAR, Acute Myeloid Leukemia Trial in Hefei (Chimeric antigen receptor T cells (car-t))

    Recruiting
    • CAR
    • Acute Myeloid Leukemia
    • Chimeric antigen receptor T cells (car-t)
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Mar 4, 2021

    Solid Tumor Trial in United States (drug, combination product, biological)

    Recruiting
    • Solid Tumor
    • Pembrolizumab
    • +2 more
    • Sacramento, California
    • +6 more
    Jan 3, 2023

    Acute Myeloid Leukemia (AML) Trial in Worldwide (Placebo, Venetoclax, Cytarabine)

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • Placebo
    • +2 more
    • Tampa, Florida
    • +108 more
    Jul 15, 2022

    Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)

    Active, not recruiting
    • Sarcoma, Soft Tissue
    • Changsha, Hunan, China
      Xiangya Hospital Central South University
    Oct 29, 2023

    Acute Myeloid Leukemia Trial in United States (ERAS-007, ERAS-601, Gilteritinib)

    Withdrawn
    • Acute Myeloid Leukemia
    • San Francisco, California
    • +3 more
    Jun 13, 2022

    Leukemia, Acute Myeloid (AML) Trial in Worldwide (gilteritinib, LoDAC (Low Dose Cytarabine), Azacitidine)

    Active, not recruiting
    • Leukemia, Acute Myeloid (AML)
    • Birmingham, Alabama
    • +125 more
    Aug 9, 2022

    Metastatic Sarcoma, Sarcoma Trial in Seattle (Assessment, Questionnaire Administration, Interview)

    Not yet recruiting
    • Metastatic Sarcoma
    • Sarcoma
    • Assessment
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Apr 27, 2023

    Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

    Completed
    • Objective Response
    • Overall Survival
    • VIA combination treatment
    • Beijing, China
      Peking University People's Hospital
    Dec 9, 2022

    Kaposi Sarcoma Trial in Worldwide (Propranolol)

    Not yet recruiting
    • Kaposi Sarcoma
    • Buenos Aires, Argentina
    • +8 more
    Mar 22, 2023

    Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

    Recruiting
    • Advanced Differentiated Thyroid Gland Carcinoma
    • +102 more
    • Cabozantinib S-malate
    • Nivolumab
    • Chicago, Illinois
    • +2 more
    Apr 5, 2022

    Sarcoma Trial in Columbus (Educational Intervention, Quality-of-Life Assessment, Survey Administration)

    Completed
    • Sarcoma
    • Educational Intervention
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 26, 2022

    Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )

    Active, not recruiting
    • Alveolar Soft Part Sarcoma
    • +3 more
    • Phoenix, Arizona
    • +22 more
    Nov 1, 2022

    Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)

    Recruiting
    • Liver Metastases
    • +10 more
    • DNX-2440
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Mar 28, 2022

    Soft Tissue Sarcoma Trial (Cadonilimab)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • Cadonilimab
    • (no location specified)
    Dec 9, 2022

    Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)

    Recruiting
    • Ewing Sarcoma
    • +6 more
    • FoundationOne Liquid CDx
    • Los Angeles, California
    • +14 more
    Oct 5, 2023

    Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors Trial in France (Sampling on blood, bone marrow and

    Recruiting
    • Neuroblastoma
    • +5 more
    • Sampling on blood, bone marrow and cerebrospinal fluid
    • Amiens, France
    • +29 more
    Feb 23, 2022

    Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

    Recruiting
    • Advanced Sarcoma
    • +2 more
    • Santa Monica, California
      Sarcoma Oncology Center
    Dec 5, 2022

    Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

    Recruiting
    • Ewing Sarcoma
    • Ewing-Like Sarcoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Aug 18, 2022

    Soft Tissue Sarcoma Trial in Beijing (Fluzoparib, Preoperative moderately fractionated radiotherapay)

    Recruiting
    • Soft Tissue Sarcoma
    • Fluzoparib
    • Preoperative moderately fractionated radiotherapay
    • Beijing, Beijing, China
    • +1 more
    Jul 3, 2023